Financials
- Market Capitalization 45.18 M
- Employee 1
- Founded 1998
- CEO N/A
- Website www.alaunos.com
- Headquarter Delaware, United States
- FIGI BBG000FWCC57
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4270 | ATYR aTyr Pharma, Inc. - Common Stock | 0.48 USD | 0.00% | 0.00% | -20.00% | -50.52% | 47.06 M USD | ||
| 4271 | INMB INmune Bio Inc. - Common stock | 1.77 USD | +4.73% | +3.51% | +9.26% | -30.04% | 47.06 M USD | ||
| 4284 | TCRX TScan Therapeutics, Inc. - Common Stock | 0.74 USD | -2.63% | -9.76% | -25.25% | -56.47% | 45.19 M USD | ||
| 4288 | MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.22 USD | 0.00% | +0.83% | +4.27% | -15.28% | 45.93 M USD |
Frequently asked questions about Alaunos Therapeutics, Inc. - Common Stock
What is the Alaunos Therapeutics, Inc. - Common Stock stock price today?
The current price of Alaunos Therapeutics, Inc. - Common Stock (TCRT) is 1.85. Over the past 24 hours, the stock has changed by -1.60%. Follow the TCRT chart for real-time price dynamics.
What is the stock ticker of Alaunos Therapeutics, Inc. - Common Stock?
Alaunos Therapeutics, Inc. - Common Stock trades under the ticker TCRT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Alaunos Therapeutics, Inc. - Common Stock stock going up?
TCRT has changed by -4.64% over the last week, -18.50% over the last month, and -30.69% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Alaunos Therapeutics, Inc. - Common Stock?
Alaunos Therapeutics, Inc. - Common Stock currently has a market capitalization of 45.18 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Alaunos Therapeutics, Inc. - Common Stock earnings last quarter?
Last quarter, Alaunos Therapeutics, Inc. - Common Stock reported earnings of -0.59 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Alaunos Therapeutics, Inc. - Common Stock revenue for the last quarter?
Alaunos Therapeutics, Inc. - Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Alaunos Therapeutics, Inc. - Common Stock net income for the last quarter?
Alaunos Therapeutics, Inc. - Common Stock reported net income of -1.01 M for the last quarter. The previous quarter showed -893 K, which means net income changed by -12.65%.
How many employees does Alaunos Therapeutics, Inc. - Common Stock have?
As of the latest available data, Alaunos Therapeutics, Inc. - Common Stock has 1 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Alaunos Therapeutics, Inc. - Common Stock stock?
You can buy Alaunos Therapeutics, Inc. - Common Stock (TCRT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Alaunos Therapeutics, Inc. - Common Stock stock?
Investing in Alaunos Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TCRT chart and related analysis on metatrader.com as part of your research.